CAMPBELL BRADLEY L (President and CEO) sold 6.5% of their position (77.93K shares) of AMICUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $846.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/17/2025ACC: 0001193125-25-323151
DirectorOfficer· President and CEO
Since Mar 2026
-77.93K
Net shares
Net seller
$846.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
70.43K acquired · 148.35K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+70.43K
Price / share
$9.03
Trade value
$635.95K
% of position
6.2%
12/15/2025
1.14M→1.21M
Common Stock
Direct
Shares
−77.93K
Price / share
$10.86
Trade value
$846.01K
% of position
6.5%
12/15/2025
1.21M→1.13M
Total
Net shares
−7.50K
Net value
-$210.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2025 | M · Option Exercise | +70.43K | $9.03 | $635.95K | 6.2% | 1.14M | 1.21M |
| Common Stock Direct | 12/15/2025 | S · Sale | −77.93K | $10.86 | $846.01K | 6.5% | 1.21M | 1.13M |
| Total | −7.50K | -$210.06K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
70.43K shares
Shares
−70.43K
Strike price
9.03
Held after
0.00
Exercisable
—
12/15/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock70.43K shares | 12/15/2025 | M · Option Exercise | −70.43K | 9.03 | — | 0.00 |